GLP-1 Drug Effectiveness Reduced by Genetic Variants
Key Points Summary Genetic variants in the PAM enzyme may reduce response to GLP-1 receptor agonists Around 10% of individuals…
Edition: International
Monday 13 April, 2026
Trending
GLP-1 Drug Effectiveness Reduced by Genetic Variants
Key Points Summary Genetic variants in the PAM enzyme may reduce response to GLP-1 receptor agonists Around 10% of individuals…
Medical Innovations
Phage Therapy Study Reveals RNA-Based Infection Control
Key Takeaways (Quick Summary) Researchers uncovered how bacteriophages use a small RNA molecule (PreS) to control bacterial gene expression. PreS…
COVID-19
Study Reveals Cold May Impact SARS-CoV-2 Infection Rates
The Unexpected Protective Role of Rhinoviruses in COVID-19 A groundbreaking study from National Jewish Health has revealed an intriguing phenomenon:…
Heart, Lung, & Brain Risks Persist in COVID-19 Survivors
A French nationwide study reveals that individuals hospitalized with COVID-19 remain at an increased risk of death and organ-related complications…
How COVID-19 and Vaccines Differ in Heart Inflammation
A team of international researchers led by the Max Delbrück Center for Molecular Medicine in Berlin has identified distinct immune…
Health and Wellness
GLP-1 Drug Effectiveness Reduced by Genetic Variants
Key Points Summary Genetic variants in the PAM enzyme may reduce response to GLP-1 receptor agonists Around 10% of individuals…
TB Vaccines Show Safety but Limited Protection in Large Trial
Key Highlights Two candidate Tuberculosis vaccines, VPM1002 and Immuvac, demonstrated strong safety profiles No overall protection against pulmonary TB or…
Drug Overdose Spike 2025 Was a Modeling Error
Quick Summary A reported U.S. drug overdose spike in 2025 was not real. A study from Northwestern University Feinberg School…